In addition, the decreased expression of ARID1A in liver tumors is observed to be tightly correlated with overall metastasis such as distant metastasis, local lymph node, and poor prognosis, indicating ARID1A could be a prognostic biomarker for HCC (37, 38). Here, ARID1A is linked to hepatocellular carcinoma.